What is Neuromyelitis Optica (NMO), also known as Devic's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Definition and Characteristics of Neuromyelitis Optica (NMO)

  • Neuromyelitis optica (NMO), also known as Devic's disease, is an autoimmune, inflammatory, and demyelinating central nervous system disorder that primarily affects the optic nerve and spinal cord 1, 2, 3, 4, 5.
  • It is a distinct disorder from multiple sclerosis (MS), with different immunopathological, clinical, prognostic, and therapeutic characteristics 1, 2, 3, 4.
  • The disease is characterized by the presence of antibodies directed against aquaporin-4 (anti-AQP4 or NMO-IgG) in the majority of cases, which distinguishes it from MS 1, 3, 4.

Clinical Features and Diagnosis

  • NMO is a debilitating disorder that damages a person's health, with a relapsing course in most cases 1, 2, 3, 4.
  • The disease predominantly targets the optic nerves and spinal cord, but can also affect certain regions of the brain 2, 3.
  • Diagnostic criteria have been enriched with the recent description of the humoral disorder underlying NMO, including the presence of anti-AQP4 antibodies and characteristic magnetic resonance imaging (MRI) findings 1, 3, 4.

Treatment and Prognosis

  • The treatment of NMO is still challenging, with current options being far from ideal 1.
  • Treatment in the acute phase includes intravenous steroids and plasma exchange therapy, while immunosuppressive agents are recommended for prophylaxis of relapses 3, 4.
  • Relapsing NMO has a poor prognosis, and therapy is necessary as early as possible in the disease course to prevent attack-related disability 4.

References

Research

[Neuromyelitis optica: a clinical update].

Revista de neurologia, 2010

Research

Neuromyelitis optica spectrum disorder: an overview.

Acta neurobiologiae experimentalis, 2020

Research

Devic's neuromyelitis optica: a critical review.

Arquivos de neuro-psiquiatria, 2008

Research

Neuromyelitis optica.

International MS journal, 2006

Research

The borderland of neuromyelitis optica.

Practical neurology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.